News

KIMMTRAK® (tebentafusp-tebn) net revenues of $98.0 million in Q2 2025, growing by 30% year-over-year Phase 3 TEBE-AM trial on track to complete enrollment in 1H 2026 Dose selection for PRISM-MEL-301 ...
A large new study will follow the health and well-being of thousands of transgender and gender nonconforming young people in the UK.
RESEARCHERS have found that an artificial intelligence model combining data from wearable glucose monitors, gut microbiome ...
KIMMTRAK® (tebentafusp-tebn) net revenues of $98.0 million in Q2 2025, growing by 30% year-over-year Phase 3 TEBE-AM trial on track to complete enrollment in 1H 2026 Dose selection for PRISM-MEL-301 ...
If we've got vaccines for so many other viruses - including Covid-19, which emerged only a few years ago - why don't we have ...
A Mediterranean diet during pregnancy significantly alters the maternal gut microbiome, increasing beneficial bacteria, while ...
Society of Urologic Oncology Award: Jianhua Xiong, PhD, will receive support for a two-year research project titled “Lipid ...
The 2025 World Bronchiectasis Conference highlighted new research on bronchiectasis and NTM - plus an emerging ...
OmniAb, Inc. ( NASDAQ: OABI) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Kurt A. Gustafson - Executive VP of Finance & CFO Matthew W. Foehr - President, CEO & Director ...
Q2 2025 Earnings Call Transcript August 6, 2025 Operator: Good day, and thank you for standing by. Welcome to the Q2 2025 ...
No supplement is going to dramatically improve your sleep, but some may offer modest benefits with minimal side effects.